BrainStorm to Continue with Planned Phase 3b Trial and Remains Committed to Advancing Access for People Living with ALS NEW YORK, July 8, 2025 /PRNewswire/ -- BrainStorm ...

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative ...

Commonly prescribed medications for anxiety, depression and sleep disorders may be associated with a higher risk of ...

Brain-machine interfaces (BMIs) are becoming lifelines for people facing severe motor impairments. For many individuals with conditions like amyotrophic lateral sclerosis (ALS) or spinal cord injuries ...

The FDA granted orphan drug designation to Sineugene Therapeutics' SNUG01, a first-in-class experimental gene therapy for ...

On July 4, 1776, the Continental Congress adopted the Declaration of Independence, proclaiming U.S. independence from Britain ...

A Q&A with author and activist Mindy Uhrlaub, who shares how she is using her voice to raise awareness and support for the ...

Tech billionaire Elon Musk’s Neuralink is one of the most talked about players in the BCI field, but the first product to ...

ALS is a slow progressing disease that doesn’t show symptoms right away. Dropping things often can be an early sign.

Unlike previous systems that convert brain signals into text, this BCI synthesizes actual speech almost instantaneously. The ...

The Food and Drug Administration has granted Fast Track designation to AMX0114 for the treatment of amyotrophic lateral sclerosis (ALS).

People from the punk and hardcore scenes who were on tour with Keil have remembered how kind he was. Scientists are finding new techniques to slow down the growth of amyotrophic lateral sclerosis (ALS ...